Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

The purpose of this study is to determine whether RX-10100 are effective in the treatment of Major Depressive Disorder (MDD).

Key facts

Study ID

NCT01273376

Run by

Rexahn Pharmaceuticals, Inc.

People needed

314

Starts

2010-12-01

Expected to finish

2011-10-01

Last updated by the study team

2013-11-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate to severe MDD as determined by the DSM-IV-TR Axis 1 Disorders and by the Montgomery Asberg Depression Rating Scale (MADRS).

You may not qualify if…

• Women who are pregnant, women who will be breastfeeding during the study, and women with childbearing potential who are not willing to practice a reliable method of birth control
• Depressive episode duration of less than 1 month
• Lifetime history of any psychotic disorders
• Anxiety disorders
• Significant suicidality
• Clinically significant medical conditions

Where it is running

• Rexahn Investigative Site — Cerritos, California, United States
• Rexahn Investigative Site — Escondido, California, United States
• Rexahn Investigative Site — Los Angeles, California, United States
• Rexahn Investigative Site — National City, California, United States
• Rexahn Investigative Site — Oceanside, California, United States
• Rexahn Investigative Site — Orange, California, United States
• Rexahn Investigative Site — San Diego, California, United States
• Rexahn Investigative Site — Denver, Colorado, United States
• Rexahn Investigative Site — Brooksville, Florida, United States
• Rexahn Investigative Site — Gainesville, Florida, United States
• Rexahn Investigative Site — Jacksonville, Florida, United States
• Rexahn Investigative Site — Miami Beach, Florida, United States
• Rexahn Investigative Site — Orlando, Florida, United States
• Rexahn Investigative Site — St. Petersburg, Florida, United States
• Rexahn Investigative Site — Tampa, Florida, United States
• Rexahn Investigative Site -2 — Atlanta, Georgia, United States
• Rexahn Investigative Site — Atlanta, Georgia, United States
• Rexahn Investigative Site — Oak Brook, Illinois, United States
• Rexahn Investigative Site — Vernon Hills, Illinois, United States
• Rexahn Investigative Site — Owensboro, Kentucky, United States
• Rexahn Investigative Site — Novi, Michigan, United States
• Rexahn Investigative Site — Las Vegas, Nevada, United States
• Rexahn Investigative site — Cherry Hill, New Jersey, United States
• Rexahn Investigative Site — Albuquerque, New Mexico, United States
• Rexahn Investigative Site — Fresh Meadows, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.